Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FK741
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,932
Award facts
- Contract value 100% obligated
- $15,931.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada (abiraterone acetate) 60 mg tablets in quantities of 120 units, valued at $15,931.60. This non-set-aside contract, executed on December 22, 2025, with an ultimate completion date of January 14, 2026, utilizes firm fixed pricing. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary pharmaceutical distribution operations.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen leverages this prime contract vehicle to supply military and veteran medical supply chains with a broad portfolio of medications and medical commodities. The current award supports federal procurement of Erleada, an oncology medication used in prostate cancer treatment, demonstrating the company's role in delivering specialized pharmaceutical products across multiple therapeutic domains to support Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FK741?
SPE2DR26FK741 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FK741 worth?
The government has obligated $15,932 on SPE2DR26FK741.
Is contract SPE2DR26FK741 an order under another contract?
Yes. SPE2DR26FK741 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK741 competed?
The extent of competition for SPE2DR26FK741 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award